662 related articles for article (PubMed ID: 2511223)
1. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
Staneck JL; Glenn S; DiPersio JR; Leist PA
J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
Clark RB; Sanders CC; Pakiz CB; Hostetter MK
Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
Ismaeel NA
Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
Hindler JA; Bruckner DA
J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Sceptor Pseudomonas Plus MIC Panel with agar dilution for susceptibility testing of Pseudomonas aeruginosa.
Joyce LF; Stockman K; Downes J; Andrew JH
J Clin Microbiol; 1992 Oct; 30(10):2714-6. PubMed ID: 1400973
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.
Joyce LF; Downes J; Stockman K; Andrew JH
J Clin Microbiol; 1992 Oct; 30(10):2709-13. PubMed ID: 1400972
[TBL] [Abstract][Full Text] [Related]
7. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.
Kohner PC; Patel R; Uhl JR; Garin KM; Hopkins MK; Wegener LT; Cockerill FR
J Clin Microbiol; 1997 Dec; 35(12):3258-63. PubMed ID: 9399530
[TBL] [Abstract][Full Text] [Related]
8. Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides.
Barry AL; Reller LB; Miller GH; Washington JA; Schoenknect FD; Peterson LR; Hare RS; Knapp C
J Clin Microbiol; 1992 Mar; 30(3):585-9. PubMed ID: 1551973
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
Meyer RD; Draus LL; Pasieczinik KA
Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a commercial microdilution system for quantitative susceptibility testing of aminoglycosides against multidrug-resistant, gram-negative bacilli.
Peterson LR; Gerding DN; Johnson MM; Cherne JE; Opfer BJ; Hall WH
Antimicrob Agents Chemother; 1980 Jan; 17(1):20-3. PubMed ID: 7352748
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.
Woolfrey BF; Lally RT; Ederer MN; Quall CO
J Clin Microbiol; 1984 Apr; 19(4):502-5. PubMed ID: 6425360
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Khan M; Ma K; Wan I; Willcox MD
Cont Lens Anterior Eye; 2023 Jun; 46(3):101819. PubMed ID: 36732125
[TBL] [Abstract][Full Text] [Related]
13. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT
J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the AMS gram-negative susceptibility flex panel GNS-V and agar disk diffusion for testing of Pseudomonas aeruginosa.
Henry DA; Smith JA; Jones MA
J Clin Microbiol; 1987 Mar; 25(3):586-7. PubMed ID: 3106408
[TBL] [Abstract][Full Text] [Related]
15. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
Barry AL; Miller GH; Thornsberry C; Hare RS; Jones RN; Lorber RR; Ferraresi R; Cramer C
Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
[TBL] [Abstract][Full Text] [Related]
16. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum.
Cherne JE; Peterson LR
Antimicrob Agents Chemother; 1980 Jul; 18(1):210-1. PubMed ID: 6774664
[TBL] [Abstract][Full Text] [Related]
17. Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
Cox HU; Luther DG
Am J Vet Res; 1980 Jun; 41(6):906-9. PubMed ID: 6776851
[TBL] [Abstract][Full Text] [Related]
18. Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.
Woolfrey BF; Fox JM; Quall CO; Lally RT
Antimicrob Agents Chemother; 1983 Nov; 24(5):764-70. PubMed ID: 6419674
[TBL] [Abstract][Full Text] [Related]
19. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
20. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
Christe M; Vaudaux P; Waldvogel FA
Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
